JAK2 and acute graft versus host disease: The findings from this study suggest that the occurrence of the JAK2 haplotypeGGCC_46/1 in both recipients and donors significantly affected the development of acute graft-versus-host disease, confirming that JAK2 polymorphisms may have an influence on cytokines signaling pathways [61].